Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1178879.
Total stock buying since 2007: $164,927,777.
Total stock sales since 2007: $289,464,081.
Total stock option exercises since 2007: $43,076,426.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 400 | $4,000 | 400 | $3,611 |
| 2024 | 0 | $0 | 399,658 | $5,124,634 | 182,067 | $1,360,541 |
| 2023 | 0 | $0 | 813,767 | $10,307,679 | 457,240 | $2,081,221 |
| 2022 | 0 | $0 | 424,370 | $4,449,738 | 116,155 | $466,726 |
| 2021 | 45,105 | $451,689 | 557,791 | $7,173,882 | 411,757 | $2,127,182 |
| 2020 | 11,000 | $175,512 | 1,681,390 | $24,511,559 | 1,284,060 | $8,873,723 |
| 2019 | 4,945 | $49,796 | 572,269 | $6,783,107 | 547,724 | $2,955,368 |
| 2018 | 1,235,827 | $15,744,014 | 301,765 | $4,590,161 | 201,765 | $1,644,814 |
| 2017 | 1,501,395 | $18,395,032 | 971,072 | $12,606,562 | 913,823 | $11,449,856 |
| 2016 | 592,950 | $3,020,945 | 1,260,420 | $8,649,277 | 156,358 | $50,864 |
| 2015 | 810,000 | $5,440,410 | 1,080,786 | $13,931,432 | 1,273,641 | $11,766,749 |
| 2014 | 6,467,084 | $30,224,665 | 11,682,909 | $62,446,695 | 16,491 | $10,521 |
| 2013 | 1,525,000 | $3,085,000 | 0 | $0 | 0 | $0 |
| 2012 | 9,361,554 | $55,128,673 | 0 | $0 | 49,931 | $31,955 |
| 2011 | 30,000 | $162,800 | 2,250 | $16,875 | 2,250 | $1,435 |
| 2010 | 11,898 | $43,903 | 0 | $0 | 0 | $0 |
| 2009 | 20,000 | $82,600 | 71,908 | $765,927 | 5,924 | $8,466 |
| 2008 | 1,834,162 | $27,685,294 | 677,689 | $127,429,143 | 153,582 | $191,652 |
| 2007 | 461,042 | $5,237,444 | 44,894 | $673,410 | 81,102 | $51,742 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-18 | Crowley John F (Chairman & CEO) | Sale | 2,214 | 8.04 | 17,793 |
| 2022-04-07 | Rosenberg Ellen (Chief Legal Officer) | Sale | 11,018 | 9.06 | 99,801 |
| 2022-03-18 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,940 | 10.00 | 109,421 |
| 2022-03-18 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,940 | 3.53 | 38,618 |
| 2022-03-04 | Sblendorio Glenn (Director) | Option Ex | 15,000 | 4.79 | 71,850 |
| 2022-01-18 | Crowley John F (Chairman & CEO) | Sale | 8,564 | 10.23 | 87,609 |
| 2022-01-05 | Crowley John F (Chairman & CEO) | Sale | 63,543 | 12.18 | 774,144 |
| 2022-01-03 | Campbell Bradley L (Chief Operating Officer) | Sale | 5,470 | 11.86 | 64,879 |
| 2022-01-03 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 5,470 | 3.53 | 19,309 |
| 2021-12-22 | Campbell Bradley L (Chief Operating Officer) | Sale | 3,000 | 11.70 | 35,097 |
| 2021-12-22 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 3,000 | 4.38 | 13,140 |
| 2021-12-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,515 | 11.00 | 115,707 |
| 2021-12-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,515 | 4.38 | 46,055 |
| 2021-11-15 | Crowley John F (Chairman & CEO) | Sale | 24,935 | 11.75 | 292,961 |
| 2021-11-15 | Crowley John F (Chairman & CEO) | Option Ex | 24,935 | 4.38 | 109,215 |
| 2021-11-03 | Crowley John F (Chairman & CEO) | Sale | 27,739 | 12.00 | 332,868 |
| 2021-11-03 | Crowley John F (Chairman & CEO) | Option Ex | 27,739 | 3.82 | 105,962 |
| 2021-11-01 | Crowley John F (Chairman & CEO) | Sale | 7,819 | 10.80 | 84,453 |
| 2021-11-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,515 | 11.32 | 119,050 |
| 2021-11-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,515 | 4.38 | 46,055 |
| 2021-11-01 | Whitman Burke W (Director) | Buy | 1,500 | 10.49 | 15,735 |
| 2021-10-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 11.22 | 246,862 |
| 2021-10-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 4.38 | 96,360 |
| 2021-10-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 10.00 | 75,000 |
| 2021-10-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,515 | 10.00 | 105,150 |
| 2021-10-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,515 | 4.38 | 46,055 |
| 2021-10-01 | Whitman Burke W (Director) | Buy | 1,500 | 9.56 | 14,346 |
| 2021-09-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 11.08 | 243,826 |
| 2021-09-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 4.38 | 96,360 |
| 2021-09-03 | Prout Samantha (Principal Accounting Officer) | Sale | 4,925 | 12.01 | 59,168 |
| 2021-09-03 | Prout Samantha (Principal Accounting Officer) | Option Ex | 4,925 | 9.79 | 48,240 |
| 2021-09-03 | Crowley John F (Chairman & CEO) | Sale | 5,238 | 12.02 | 62,945 |
| 2021-09-03 | Crowley John F (Chairman & CEO) | Option Ex | 5,238 | 3.67 | 19,249 |
| 2021-09-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 11.50 | 86,250 |
| 2021-09-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,515 | 11.50 | 120,901 |
| 2021-09-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,515 | 4.38 | 46,055 |
| 2021-09-01 | Whitman Burke W (Director) | Buy | 1,500 | 11.41 | 17,115 |
| 2021-08-23 | Prout Samantha (Principal Accounting Officer) | Sale | 5,045 | 11.00 | 55,495 |
| 2021-08-16 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 10.27 | 225,918 |
| 2021-08-16 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 4.38 | 96,360 |
| 2021-08-05 | Crowley John F (Chairman & CEO) | Sale | 37,000 | 10.03 | 371,036 |
| 2021-08-05 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 4.38 | 96,360 |
| 2021-08-05 | Campbell Bradley L (Chief Operating Officer) | Sale | 21,028 | 10.02 | 210,679 |
| 2021-08-05 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 21,028 | 4.38 | 92,102 |
| 2021-08-02 | Whitman Burke W (Director) | Buy | 1,500 | 9.28 | 13,919 |
| 2021-07-12 | Crowley John F (Chairman & CEO) | Sale | 14,885 | 9.31 | 138,653 |
| 2021-07-01 | Whitman Burke W (Director) | Buy | 1,500 | 9.60 | 14,400 |
| 2021-06-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 10.26 | 225,632 |
| 2021-06-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 4.38 | 96,360 |
| 2021-06-01 | Whitman Burke W (Director) | Buy | 1,500 | 9.24 | 13,861 |
| 2021-05-25 | Bleil Lynn Dorsey (Director) | Buy | 28,605 | 8.74 | 250,007 |
| 2021-05-18 | Raab Michael (Director) | Option Ex | 5,634 | 7.56 | 42,593 |
| 2021-05-03 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 10.28 | 77,092 |
| 2021-05-03 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,514 | 10.27 | 107,968 |
| 2021-05-03 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,514 | 6.45 | 67,815 |
| 2021-05-03 | Mcglynn Margaret G (Director) | Sale | 10,000 | 10.27 | 102,700 |
| 2021-05-03 | Mcglynn Margaret G (Director) | Option Ex | 10,000 | 7.51 | 75,100 |
| 2021-05-03 | Whitman Burke W (Director) | Buy | 1,500 | 10.21 | 15,315 |
| 2021-04-22 | Crowley John F (Chairman & CEO) | Sale | 7,683 | 10.01 | 76,899 |
| 2021-04-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 10.10 | 222,090 |
| 2021-04-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 6.45 | 141,900 |
| 2021-04-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 10.00 | 75,000 |
| 2021-04-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,514 | 10.04 | 105,507 |
| 2021-04-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,514 | 6.45 | 67,815 |
| 2021-04-01 | Whitman Burke W (Director) | Buy | 1,500 | 10.00 | 15,000 |
| 2021-03-22 | Crowley John F (Chairman & CEO) | Sale | 7,682 | 10.29 | 79,063 |
| 2021-03-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 10.77 | 236,984 |
| 2021-03-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 6.45 | 141,900 |
| 2021-03-05 | Quimi Daphne (Chief Financial Officer) | Option Ex | 16,628 | 2.94 | 48,886 |
| 2021-03-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 11.85 | 88,882 |
| 2021-03-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,514 | 11.84 | 124,517 |
| 2021-03-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,514 | 6.45 | 67,815 |
| 2021-03-01 | Whitman Burke W (Director) | Buy | 1,500 | 12.40 | 18,600 |
| 2021-02-22 | Crowley John F (Chairman & CEO) | Sale | 7,682 | 11.98 | 92,030 |
| 2021-02-16 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 12.26 | 269,698 |
| 2021-02-16 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 6.45 | 141,900 |
| 2021-02-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 19.08 | 143,077 |
| 2021-02-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,514 | 19.08 | 200,575 |
| 2021-02-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,514 | 6.45 | 67,815 |
| 2021-02-01 | Whitman Burke W (Director) | Buy | 1,500 | 19.09 | 28,636 |
| 2021-01-20 | Crowley John F (Chairman & CEO) | Sale | 50,000 | 21.51 | 1,075,350 |
| 2021-01-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 22.24 | 489,368 |
| 2021-01-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 6.45 | 141,900 |
| 2021-01-04 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 22.17 | 166,305 |
| 2021-01-04 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,514 | 22.17 | 233,126 |
| 2021-01-04 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,514 | 6.45 | 67,815 |
| 2021-01-04 | Whitman Burke W (Director) | Buy | 1,500 | 23.17 | 34,755 |
| 2020-12-21 | Quimi Daphne (Chief Financial Officer) | Sale | 5,000 | 24.09 | 120,475 |
| 2020-12-21 | Quimi Daphne (Chief Financial Officer) | Option Ex | 5,000 | 2.94 | 14,700 |
| 2020-12-15 | Quimi Daphne (Chief Financial Officer) | Option Ex | 30,321 | 3.33 | 100,817 |
| 2020-12-15 | Crowley John F (Chairman & CEO) | Sale | 22,000 | 23.91 | 526,108 |
| 2020-12-15 | Crowley John F (Chairman & CEO) | Option Ex | 22,000 | 6.45 | 141,900 |
| 2020-12-15 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 20,828 | 5.42 | 112,783 |
| 2020-12-14 | Do Hung (Chief Science Officer) | Sale | 111,125 | 23.88 | 2,653,331 |
| 2020-12-01 | Crowley John F (Chairman & CEO) | Sale | 7,500 | 22.77 | 170,775 |
| 2020-12-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 24,783 | 22.77 | 564,184 |
| 2020-12-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 24,783 | 2.52 | 62,453 |
| 2020-12-01 | Whitman Burke W (Director) | Buy | 1,500 | 23.50 | 35,250 |
| 2020-11-04 | Prout Samantha (Principal Accounting Officer) | Sale | 5,931 | 20.00 | 118,620 |
| 2020-11-04 | Prout Samantha (Principal Accounting Officer) | Option Ex | 5,931 | 12.46 | 73,900 |
| 2020-11-02 | Crowley John F (Chairman & CEO) | Sale | 33,875 | 17.87 | 605,278 |
| 2020-11-02 | Crowley John F (Chairman & CEO) | Option Ex | 23,975 | 5.96 | 142,891 |
| 2020-11-02 | Campbell Bradley L (Chief Operating Officer) | Sale | 24,782 | 17.87 | 442,804 |
| 2020-11-02 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 24,782 | 2.52 | 62,450 |
| 2020-11-02 | Whitman Burke W (Director) | Buy | 1,500 | 18.01 | 27,015 |
| 2020-10-09 | Do Hung (Chief Science Officer) | Sale | 193,700 | 15.03 | 2,911,311 |
| 2020-10-09 | Do Hung (Chief Science Officer) | Option Ex | 193,700 | 9.97 | 1,931,770 |
| 2020-10-02 | Quimi Daphne (Chief Financial Officer) | Option Ex | 11,000 | 2.45 | 26,950 |
| 2020-10-01 | Quimi Daphne (Chief Financial Officer) | Sale | 5,000 | 14.02 | 70,100 |
| 2020-10-01 | Quimi Daphne (Chief Financial Officer) | Option Ex | 5,000 | 2.94 | 14,700 |
| 2020-10-01 | Crowley John F (Chairman & CEO) | Sale | 29,900 | 14.02 | 419,108 |
| 2020-10-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.96 | 119,200 |
| 2020-10-01 | Whitman Burke W (Director) | Buy | 1,500 | 14.28 | 21,412 |
| 2020-09-30 | Barth Jay (Chief Medical Officer) | Sale | 4,064 | 14.51 | 58,952 |
| 2020-09-30 | Barth Jay (Chief Medical Officer) | Option Ex | 4,064 | 2.29 | 9,306 |
| 2020-09-28 | Campbell Bradley L (Chief Operating Officer) | Sale | 24,782 | 13.89 | 344,197 |
| 2020-09-28 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 24,782 | 2.52 | 62,450 |
| 2020-09-01 | Crowley John F (Chairman & CEO) | Sale | 29,900 | 14.18 | 423,862 |
| 2020-09-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.96 | 119,200 |
| 2020-09-01 | Whitman Burke W (Director) | Buy | 1,500 | 14.62 | 21,930 |
| 2020-08-31 | Barth Jay (Chief Medical Officer) | Sale | 28,750 | 14.74 | 423,746 |
| 2020-08-31 | Barth Jay (Chief Medical Officer) | Option Ex | 28,750 | 6.10 | 175,375 |
| 2020-08-17 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 14.89 | 297,820 |
| 2020-08-17 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-08-05 | Prout Samantha (Principal Accounting Officer) | Sale | 198 | 15.05 | 2,979 |
| 2020-08-05 | Prout Samantha (Principal Accounting Officer) | Option Ex | 198 | 10.04 | 1,987 |
| 2020-08-03 | Crowley John F (Chairman & CEO) | Sale | 39,655 | 14.78 | 586,100 |
| 2020-08-03 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.96 | 119,200 |
| 2020-08-03 | Campbell Bradley L (Chief Operating Officer) | Sale | 10,000 | 14.78 | 147,780 |
| 2020-08-03 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,000 | 6.06 | 60,599 |
| 2020-08-03 | Whitman Burke W (Director) | Buy | 1,500 | 14.53 | 21,795 |
| 2020-07-27 | Barth Jay (Chief Medical Officer) | Sale | 30,000 | 15.05 | 451,380 |
| 2020-07-27 | Barth Jay (Chief Medical Officer) | Option Ex | 30,000 | 6.10 | 183,000 |
| 2020-07-16 | Rosenberg Ellen (Chief Legal Officer) | Sale | 30,000 | 15.26 | 457,920 |
| 2020-07-16 | Rosenberg Ellen (Chief Legal Officer) | Option Ex | 30,000 | 5.16 | 154,800 |
| 2020-07-15 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 15.54 | 310,840 |
| 2020-07-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-07-10 | Barth Jay (Chief Medical Officer) | Sale | 28,843 | 15.65 | 451,421 |
| 2020-07-10 | Barth Jay (Chief Medical Officer) | Option Ex | 28,843 | 5.13 | 147,964 |
| 2020-07-09 | Barth Jay (Chief Medical Officer) | Sale | 44,447 | 15.92 | 707,507 |
| 2020-07-09 | Barth Jay (Chief Medical Officer) | Option Ex | 44,447 | 9.99 | 444,025 |
| 2020-07-08 | Barth Jay (Chief Medical Officer) | Sale | 64,110 | 15.92 | 1,020,567 |
| 2020-07-08 | Barth Jay (Chief Medical Officer) | Option Ex | 64,110 | 9.99 | 640,458 |
| 2020-07-08 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 16.01 | 40,025 |
| 2020-07-08 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 6.06 | 15,149 |
| 2020-07-07 | Barth Jay (Chief Medical Officer) | Sale | 178,988 | 15.90 | 2,845,909 |
| 2020-07-07 | Barth Jay (Chief Medical Officer) | Option Ex | 178,988 | 9.99 | 1,788,090 |
| 2020-07-02 | Prout Samantha (Principal Accounting Officer) | Sale | 198 | 15.80 | 3,128 |
| 2020-07-02 | Prout Samantha (Principal Accounting Officer) | Option Ex | 198 | 10.04 | 1,987 |
| 2020-07-01 | Quimi Daphne (Chief Financial Officer) | Sale | 6,872 | 15.47 | 106,323 |
Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.